Form 4: Aldeyra Therapeutics Executive Sells Shares to Cover Tax Obligations

Bruce Greenberg, Interim CFO of Aldeyra Therapeutics, sold shares to cover tax withholding obligations related to the settlement of restricted stock units.

Summary

• On August 12, 2024, Bruce Greenberg, Interim Chief Financial Officer of Aldeyra Therapeutics, sold 10,834 shares of common stock.
• The sale was executed to cover tax withholding obligations upon the settlement of time-based restricted stock unit awards.
• The shares were sold at a weighted average price of $4.7363, with individual sales prices ranging from $4.46 to $5.12.
• Following the transaction, Greenberg beneficially owns 126,382 shares of Aldeyra Therapeutics common stock, which includes 7,062 shares acquired under the company's Employee Stock Purchase Plan.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing a routine stock sale for tax purposes. It doesn't convey any particularly positive or negative sentiment about the company's performance or future prospects.

Industry Context

This is a routine disclosure related to executive stock transactions and is common for publicly traded companies. It doesn't necessarily indicate a change in the company's prospects.

Stakeholder Impact

• The sale of shares by an executive could have a minor, temporary impact on the stock price, but is unlikely to have a significant long-term effect on shareholders.

Key Dates